The hemostatic defect induced by treatment with asparaginase in leukemia.
D001215:Asparaginase / Q000009:adverse effects*; D001772:Blood Cell Count; D001778:Blood Coagulation Disorders / Q000139:chemically induced*; D001780:Blood Coagulation Tests; D001792:Blood Platelets / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis; D006801:Humans; D007938:Leukemia / Q000097:blood / Q000188:drug therapy*
D005340:Fibrinogen; D001215:Asparaginase